Exact Mass: 564.4025826

Exact Mass Matches: 564.4025826

Found 28 metabolites which its exact mass value is equals to given mass value 564.4025826, within given mass tolerance error 2.56E-9 dalton. Try search metabolite list with more accurate mass tolerance error 5.12E-10 dalton.

DG(10:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C33H56O7 (564.4025826)


DG(10:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/10:0/0:0)

(2S)-2-(decanoyloxy)-3-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C33H56O7 (564.4025826)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(decanoyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C33H56O7 (564.4025826)


DG(10:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/10:0)

(2S)-3-(decanoyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C33H56O7 (564.4025826)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C33H56O7 (564.4025826)


DG(10:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C33H56O7 (564.4025826)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C33H56O7 (564.4025826)


DG(10:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C33H56O7 (564.4025826)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C33H56O7 (564.4025826)


DG(10:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C33H56O7 (564.4025826)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C33H56O7 (564.4025826)


DG(10:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C33H56O7 (564.4025826)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(10:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C33H56O7 (564.4025826)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/10:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/10:0/0:0)

C33H56O7 (564.4025826)


   

DG(10:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(10:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C33H56O7 (564.4025826)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/10:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/10:0)

C33H56O7 (564.4025826)


   

DG(10:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(10:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C33H56O7 (564.4025826)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/10:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/10:0/0:0)

C33H56O7 (564.4025826)


   

DG(10:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(10:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C33H56O7 (564.4025826)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/10:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/10:0)

C33H56O7 (564.4025826)


   

DG(10:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(10:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C33H56O7 (564.4025826)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/10:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/10:0/0:0)

C33H56O7 (564.4025826)


   

DG(10:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(10:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C33H56O7 (564.4025826)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/10:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/10:0)

C33H56O7 (564.4025826)


   
   
   

7-hydroxy-8-[5-hydroxy-8-(3-hydroxy-4,6-dimethylnon-6-en-2-yl)-10-methoxy-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]-6-methylnona-2,4-dienal

7-hydroxy-8-[5-hydroxy-8-(3-hydroxy-4,6-dimethylnon-6-en-2-yl)-10-methoxy-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]-6-methylnona-2,4-dienal

C33H56O7 (564.4025826)


   

(2e,4z)-7-hydroxy-8-[(2s,3s,5s,6r,8r,9r,10r)-5-hydroxy-8-[(6e)-3-hydroxy-4,6-dimethylnon-6-en-2-yl]-10-methoxy-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]-6-methylnona-2,4-dienal

(2e,4z)-7-hydroxy-8-[(2s,3s,5s,6r,8r,9r,10r)-5-hydroxy-8-[(6e)-3-hydroxy-4,6-dimethylnon-6-en-2-yl]-10-methoxy-3,9-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]-6-methylnona-2,4-dienal

C33H56O7 (564.4025826)